Exercise-induced bronchoconstriction (EIB) is experienced by the majority of an estimated 300 million individuals who have asthma, a condition that affects all ages and is increasing globally.

The field of exercise-induced respiratory conditions in athletes encompasses a range of transient and chronic airway alterations encountered by individuals during or after vigorous physical exertion.

Clasado Biosciences Limited, the producers and suppliers of Bimuno(R) (B-GOS), a unique patented trans-galactooligosaccharide complex, today announces the publication of results for the latest ...

At this time of year it’s not an uncommon scene: Little League baseball players wheeze as they cross home plate and try to catch their breath. Players, coaches, umpires and parents watch in dismay, ...

Mar. 23 -- WEDNESDAY, April 25 (HealthDay News) -- The U.S. Food and Drug Administration has approved the Merck asthma and allergy drug Singulair (montelukast sodium) for people aged 15 and older who ...

Bronchodilator use (total number of doses/puffs) was significantly reduced (p < 0.05) during the last 2 weeks of the fish oil diet (45 puffs; 95% CI, 34 to 51 puffs) compared to the normal diet (61 ...

Physical inactivity has long been common among children with asthma due to fears of exercise-induced bronchoconstriction (EIB). However, new evidence-based recommendations show that with proper ...

Co announces that the FDA has approved a new indication for Singulair to prevent exercise-induced bronchoconstriction (EIB; also known as exercise-induced asthma) in patients aged 15 years and older.